All products
By area
By ATC classifier
! Pharmacovigilance

ATSAT

The active substance:

 ATORVASTATIN

Indications for use:

Indications.

As dietary supplements for the treatment of patients with increased level of general cholesterin, low-density lipoprotein cholesterol (LDLC), apolipoprotein B, triglyceride, for increasing of high-density lipoprotein cholesterol (HDLC) in patients with primary hypercholesterinemia (heterozygous familial and nonheritable hypercholesterinemia), combined (mixed) hyperlipidemia (type IIa and IIb by Fredriksson classification), increased level of triglyceride in serum (type IV by Fredriksson classification) and in patients with disbetalipoproteinemia (type ІІІ by Fredriksson classification) in cases when a diet is non-effective.

For decreasing of the level of general cholesterin and LDLC in patients with homozygous familial hypercholesterinemia, if a diet and other non-medicamental drugs do not provide appropriate effect.

For patients without clinical manifestation of cardiovascular diseases with presence or absence of dislipidemia, but who have some risk factors of cardiovascular diseases with the aim of cardiovascular complications prevention. In pediatrics, the drug is also used in 10–17 aged patients with heterozygous familial hypercholesterinemia.

1 tablet contains Atorvastatin calcium which is equivalent to 10 mg or 20 mg of Atorvastatin.

Drugs for reducing the level of cholesterol and triglyceride in blood serum. HMG-CoA reductase inhibitors.

 

For detailed information, please see instruction for medical use.
Twitter
Facebook
Фармаконадзор